Supplemental breast cancer screening after negative mammography in U.S. women with dense breasts.

Foster VM, Trentham-Dietz A, Stout NK, Lee CI, Ichikawa LE, Eavey J, Henderson L, Miglioretti DL, Tosteson ANA, Bowles EA, Kerlikowske K, Sprague BL. J Natl Cancer Inst. 2024 Oct 30:djae272. doi: 10.1093/jnci/djae272. Online ahead of print. PMID: 39475439

Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis.

Baker J, Noguchi N, Marinovich ML, Sprague BL, Salisbury E, Houssami N. Breast. 2024 Sep 11;78:103807. doi: 10.1016/j.breast.2024.103807. Online ahead of print. PMID: 39270543

Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort.

Miglioretti DL, Abraham L, Sprague BL, Lee CI, Bissell MCS, Ho TH, Bowles EJA, Henderson LM, Hubbard RA, Tosteson ANA, Kerlikowske K. Ann Intern Med. 2024 Oct;177(10):1297-1307. doi: 10.7326/M24-0123. Epub 2024 Sep 3. PMID: 39222505

Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density.

Stout NK, Miglioretti DL, Su YR, Lee CI, Abraham L, Alagoz O, de Koning HJ, Hampton JM, Henderson L, Lowry KP, Mandelblatt JS, Onega T, Schechter CB, Sprague BL, Stein S, Trentham-Dietz A, van Ravesteyn NT, Wernli KJ, Kerlikowske K, Tosteson ANA. JAMA Intern Med. 2024 Oct 1;184(10):1222-1231. doi: 10.1001/jamainternmed.2024.4224. PMID: 39186304

Performance of Supplemental US Screening in Women with Dense Breasts and Varying Breast Cancer Risk: Results from the Breast Cancer Surveillance Consortium.

Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher GH, O'Meara ES, Miglioretti DL, Lee JM, Stout NK, Herschorn SD, Perry H, Weaver DL, Kerlikowske K. Radiology. 2024 Aug;312(2):e232380. doi: 10.1148/radiol.232380. PMID: 39105648

Relative Timing of Mammography and MRI for Breast Cancer Screening: Impact on Performance Evaluation.

Lee JM, Ichikawa LE, Kerlikowske K, Buist DSM, Lee CI, Sprague BL, Henderson LM, Onega T, Wernli KJ, Lowry KP, Stout NK, Tosteson ANA, Miglioretti DL. J Am Coll Radiol. 2024 Nov;21(11):1722-1732. doi: 10.1016/j.jacr.2024.06.020. Epub 2024 Jul 3. PMID: 38969253

Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.

Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard BM, Hampton JM, Caswell-Jin JL, Gangnon RE, Lu Y, Huang H, Stein S, Sun L, Gil Quessep EJ, Yang Y, Lu Y, Song J, Muñoz DF, Li Y, Kurian AW, Kerlikowske K, O'Meara ES, Sprague BL, Tosteson ANA, Feuer EJ, Berry D, Plevritis SK, Huang X, de Koning HJ, van Ravesteyn NT, Lee SJ, Alagoz O, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS. JAMA. 2024 Jun 11;331(22):1947-1960. doi: 10.1001/jama.2023.24766. PMID: 38687505

Breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer.

Smith RE, Sprague BL, Henderson LM, Kerlikowske K, Miglioretti DL, Wernli KJ, Onega T, diFlorio-Alexander RM, Tosteson ANA. Breast Cancer Res. 2024 Apr 29;26(1):73. doi: 10.1186/s13058-024-01820-x. PMID: 38685119

Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.

Sprague BL, Nowak SA, Ahern TP, Herschorn SD, Kaufman PA, Odde C, Perry H, Sowden MM, Vacek PM, Weaver DL. Radiol Imaging Cancer. 2024 May;6(3):e230161. doi: 10.1148/rycan.230161. PMID: 38578209

Breast Cancer Screening With Mammography: An Updated Decision Analysis for the U.S. Preventive Services Task Force [Internet].

Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard B, Hampton JM, Caswell-Jin J, Lu Y, Gangnon RE, Sun L, Huang H, Stein S, Quessep EG, Yang Y, Lu Y, Li Y, Song J, Muñoz DF, Kurian AW, Kerlikowske K, O’Meara ES, Sprague BL, Tosteson ANA, Berry D, Alagoz O, Plevritis SK, Huang X, de Koning H, van Ravesteyn N, Lee SJ, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS. Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Apr. Report No.: 23-05303-EF-2. PMID: 38718151

Response to Omoleye, Esserman, Olufunmilayo.

Kerlikowske K, Zhu W, Su YR, Sprague BL, O'Meara ES, Tosteson ANA, Wernli KJ, Miglioretti DL. J Natl Cancer Inst. 2024 Apr 5;116(4):629-630. doi: 10.1093/jnci/djae011. PMID: 38230817

Population Attributable Risk of Advanced-Stage Breast Cancer by Race and Ethnicity.

Kerlikowske K, Chen S, Bissell MCS, Lee CI, Tice JA, Sprague BL, Miglioretti DL. JAMA Oncol. 2024 Feb 1;10(2):167-175. doi: 10.1001/jamaoncol.2023.5242. PMID: 38060241

Extending the Breast Cancer Surveillance Consortium Model of Invasive Breast Cancer.

Gard CC, Tice JA, Miglioretti DL, Sprague BL, Bissell MCS, Henderson LM, Kerlikowske K. J Clin Oncol. 2024 Mar 1;42(7):779-789. doi: 10.1200/JCO.22.02470. Epub 2023 Nov 17. PMID: 37976443

The Importance of Outcomes Ascertainment for Accurate Assessment of the Mammography Screening Cancer Detection Rate: A Simulation Study.

Burnside ES, Lasarev MR, Sprague BL, Miglioretti DL, Alexandridis RA, Lee JM, Pisano ED, Smith RA. J Am Coll Radiol. 2024 Mar;21(3):376-386. doi: 10.1016/j.jacr.2023.09.014. Epub 2023 Nov 3. PMID: 37922974

Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.

Kerlikowske K, Zhu W, Su YR, Sprague BL, Stout NK, Onega T, O'Meara ES, Henderson LM, Tosteson ANA, Wernli K, Miglioretti DL. J Natl Cancer Inst. 2024 Feb 8;116(2):249-257. doi: 10.1093/jnci/djad201. PMID: 37897090